首页|淄博市市售畜肉及其制品中β-受体激动剂残留状况分析及暴露风险评估

淄博市市售畜肉及其制品中β-受体激动剂残留状况分析及暴露风险评估

扫码查看
目的 了解2015-2022年山东省淄博市市售畜肉和肝及其制品中β-受体激动剂残留状况,评估暴露风险.方法 随机采集不同销售环节畜肉和肝及其制品,检测β-受体激动剂残留情况,采用食品安全指数法评估风险.结果 检测溜博市市售畜肉和肝及其制品187份,检出β-受体激动剂残留9份、检出率4.8%,莱克多巴胺未检出,克伦特罗、沙丁胺醇和特布他林检出率分别为3.7%、1.1%和0.3%,β-受体激动剂检出率商店(4.7%)和农贸市场(5.1%)差异无统计学意义(x2=0.015,P=0.902).克伦特罗、沙丁胺醇和特布他林的β-受体激动剂安全指数分别为0.507、0.033和0.033.结论 淄博市市售畜肉和肝及其制品中β-受体激动剂存在不同程度的残留,但暴露风险较低,均可接受.应加强养殖环节监管,开展β-受体激动剂监测,建立食品安全风险会商机制,确保风险降到最低.
Analysis of residue of β-receptor agonists in livestock meat and products and assessment of exposure risk in Zibo city
Objective To understand the residual status of β-receptor agonists in livestock meat,liver and its products sold in the market in Zibo city of Shandong province from 2015 to 2022,and evaluate the exposure risk.Methods Livestock meat,liver and the products were randomly collected from different sales links for detecting the residue of β-receptor agonist,and the risk was evaluated by food safety index(IFS)method.Results In 187 samples,the β-receptor agonists were detected in 9 samples with a detection rate of 4.8%.The ractopamine was not detected,and the detection rate of clenbuterol,salbutamol and terbutaline was 3.7%,1.1%and 0.3%,respectively.There was no statistical difference(x2=0.015,P=0.902)between the detection rates of stores(4.7%)and farm produce fair(5.1%).The IFS of β-receptor agonist of clenbuterol,salbutamol and terbutaline was 0.507,0.033 and 0.033,respectively.Conclusions There are different degrees of residue ofβ-receptor agonist in livestock meat,liver and its products in Zibo city,but the exposure risk is low and acceptable.It is necessary to strengthen the supervision in the breeding process,carry out the β-receptor agonist monitoring,and establish a consultation mechanism for food safety risk to ensure that the exposure risk is minimized.

Livestock meat,liver and its productsβ-receptor agonistResidualExposure risk assessment

汪洋、高慧、武玉平、杨爱青、徐一凡

展开 >

山东省淄博市疾病预防控制中心,山东淄博 255026

山东省淄博市环境有机污染与人群健康监测分析重点实验室,山东淄博 255026

畜肉和肝及其制品 β-受体激动剂 残留状况 暴露风险评估

2024

疾病预防控制通报
新疆疾病预防控制中心

疾病预防控制通报

ISSN:1000-3711
年,卷(期):2024.39(2)
  • 17